Centre gives nod for Rs 4,500 crore credit support for SII, Bharat Biotech to boost COVID-19 vaccine production
The financial support came as the government decided to open up vaccination for all citizens above the age of 18 from May 1.
You Might Like
💡 newsR Knowledge: Other News Mentions
Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News
Credit: Oneindia Duration: 03:17Published
Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-oldsBharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years,..
Bharat Biotech commences direct supply of 'Covaxin' to 14 statesThe company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana,..
COVID-19: Bharat Biotech's Covaxin approved by Centre for children above 12 years? Government said THISThe tweet shared by PIB also shared a screenshot of the news that claimed that Covaxin has been approved for children.
CDC panel clears way for COVID vaccines for adolescents
Credit: Reuters - Politics Duration: 02:00Published
CDC advisers endorse Pfizer COVID-19 vaccine for kids 12 and up
Credit: ABC Action News Duration: 02:09Published
3.5 lakh fresh Covid cases, toll over 4k for 2nd day in a rowAfter remaining low for two consecutive days, fresh cases again breached the 3.5 lakh benchmark on Wednesday. Deaths also remained over 4,000 for the second day..
Related videos from verified sources